Cerner: $28.2 Billion for Hospital RecordsNarrow moat

Oracle (ORCL) — moat facet

Oracle paid $28.2 billion for hospital records that are among the hardest data in the world to move, and has yet to make them grow fast.

Cerner was a very large purchase, and it bought something unusual: records that a hospital cannot easily move. Oracle acquired Cerner on 8 June 2022 for $95.00 a share, a total purchase price of $28.2 billion1. Most of it was recorded as goodwill, $18,618 million, and intangible assets, $11,972 million2.

Cerner purchase price allocation ($M)18,618Goodwill11,972Intangible assets5,900FY2023 revenue contributedOracle Form 10-K FY2023, acquisition note
Mostly goodwill, with $5.9 billion of revenue.

Electronic health records carry switching costs even higher than a general ledger. Doctors and nurses are trained on the system, clinical workflows are built around it, and a failed migration puts patients at risk. Hospitals change record systems rarely.

The business arrived at a meaningful size. Cerner contributed $5.9 billion to Oracle's revenue in fiscal 20233, about 11.8% of the year's total4, and it is why the services line jumped from $3,205 million in fiscal 2022 to $5,594 million in fiscal 20235.

Oracle has not written it down. Its annual impairment tests did not result in a goodwill impairment charge, and it recognised no impairment in fiscal 2025 or 20246. It now sells Cerner's products as Oracle Health and says a new AI patient care system will push the business's growth "to double-digits in fiscal year 2027"7. That sentence also tells you growth is below double digits today.

The Cerner business also brought litigation risk and regulatory exposure unusual for Oracle. Health records are subject to privacy rules and government contracting, and Oracle's annual report already carries a privacy class action in the Netherlands8. The regulatory surface of Oracle has grown with every industry it has bought into.

Cerner widened the applications moat into a regulated industry. The test is whether Oracle Health reaches the double-digit growth management promised for fiscal 2027; if it does not, the $28.2 billion bought a durable franchise that is standing still.

Moat trajectory: Holding steady

No impairment; management targets double-digit Oracle Health growth in FY2027.

The number that tests this moat
Reported
Goodwill on the balance sheet
$62,261M (May 2026); $62,207M a year earlier

Mostly Cerner and earlier deals; an impairment would say an acquisition is earning less than was paid.

Source: Oracle Form 10-K, FY2026 ↗
⚠ Threats to the moat
⚠ THREAT 01
Oracle Health Is Not Yet at Double Digits
Oracle promises double-digit growth for Oracle Health in fiscal 2027, which tells you it is not growing that fast now.
References
  1. ReportedOracle acquired Cerner on 8 June 2022 for $95.00 a share, a total purchase price of $28.2 billion.
    Oracle Form 10-K for fiscal 2023 - the Cerner acquisition, its purchase price allocation and revenue contribution. — FY2023 · publ. June 2023 · source ↗
  2. ReportedMost of it was recorded as goodwill, $18,618 million, and intangible assets, $11,972 million.
    Oracle Form 10-K for fiscal 2023 - the Cerner acquisition, its purchase price allocation and revenue contribution. — FY2023 · publ. June 2023 · source ↗
  3. ReportedCerner contributed $5.9 billion to Oracle's revenue in fiscal 2023, about 11.8% of the year's total, and it is why the services line jumped from $3,205 million in fiscal 2022 to $5,594 million in fiscal 2023.
    Oracle Form 10-K for fiscal 2023 - the Cerner acquisition, its purchase price allocation and revenue contribution. — FY2023 · publ. June 2023 · source ↗
  4. Moat Explorer calcCerner contributed $5.9 billion to Oracle's revenue in fiscal 2023, about 11.8% of the year's total, and it is why the services line jumped from $3,205 million in fiscal 2022 to $5,594 million in fiscal 2023.
    Moat Explorer calculation from Oracle's reported figures ($ millions unless stated; fiscal years end 31 May). Revenue lines: software support 19,804 / 19,365 - 1 = 2.3% (FY2022-FY2026); support share 19,804 / 67,357 = 29.4%; support Q1 FY2027 4,895 / 4,955 - 1 = -1.2%; licences FY2026 4,737 / 5,201 - 1 = -8.9%; licences Q1 FY2027 655 / 766 - 1 = -14.5%; licences FY2017 to FY2026 4,737 / 6,523 - 1 = -27.4%; fourth-quarter licences 1,881 / 4,737 = 39.7%. Software (licence plus support) FY2022 5,878 + 19,365 = 25,243; FY2023 5,779 + 19,426 = 25,205; FY2026 24,541 / 24,724 - 1 = -0.7%; software share 24,541 / 67,357 = 36.4%. Cloud infrastructure FY2026 18,101 / 10,234 - 1 = 76.9%; FY2024 to FY2026 18,101 / 6,840 = 2.6 times; share 18,101 / 67,357 = 26.9%; Q1 FY2027 share 7,388 / 19,345 = 38.2%; annual run rate 7,388 x 4 = 29,552. Cloud applications FY2025 14,272 / 12,934 - 1 = 10.3%; FY2026 15,888 / 14,272 - 1 = 11.3%; share 15,888 / 67,357 = 23.6%; trailing twelve months 15,888 - 3,839 + 4,219 = 16,268. Applications ecosystem revenue 18,172 / 16,651 - 1 = 9.1%; 19,383 / 18,172 - 1 = 6.7%. Hardware segment margin 2,017 / 3,084 = 65.4% (FY2026); 1,709 / 4,152 = 41.2% (FY2017); 1,903 / 3,443 = 55.3% (FY2020); 1,932 / 3,274 = 59.0% (FY2023); 452 / 774 = 58.4% (Q1 FY2027); hardware revenue 3,084 / 4,152 - 1 = -25.7%; 3,084 / 5,205 - 1 = -40.7%; share 3,084 / 67,357 = 4.6%. Services margin 1,533 / 5,743 = 26.7% (FY2026); 993 / 5,233 = 19.0% (FY2025); 698 / 3,359 = 20.8% (FY2017); 450 / 3,106 = 14.5% (FY2020); 1,104 / 5,594 = 19.7% (FY2023); 445 / 1,414 = 31.5% (Q1 FY2027); services growth 5,743 / 5,233 - 1 = 9.7%; share 5,743 / 67,357 = 8.5%; revenue per services employee 5,743 / 34,000 = about $169,000. Cloud and software segment margin 20,801 / 30,452 = 68.3% (FY2017); 23,169 / 34,101 = 67.9% (FY2021); 26,126 / 41,086 = 63.6% (FY2023); 28,514 / 44,464 = 64.1% (FY2024); 30,930 / 49,230 = 62.8% (FY2025); 34,468 / 58,530 = 58.9% (FY2026); 7,691 / 12,907 = 59.6% (Q1 FY2026); 9,358 / 17,157 = 54.5% (Q1 FY2027); segment expenses 16,850 / 8,783 - 1 = 91.8%; segment revenue 58,530 / 44,464 - 1 = 31.6%; Q1 segment revenue 17,157 / 12,907 - 1 = 32.9%. Revenue growth 67,357 / 57,399 - 1 = 17.3%; FY2022 to FY2026 67,357 / 42,440 - 1 = 58.7%; Cerner share of FY2023 revenue 5,900 / 49,954 = 11.8%. Research and development 10,272 / 5,524 = 1.9 times; 10,272 / 67,357 = 15.3%. Sales and marketing 8,274 / 52,961 = 15.6% (FY2024); 8,651 / 57,399 = 15.1% (FY2025); 8,331 / 67,357 = 12.4% (FY2026); 8,331 / 8,651 - 1 = -3.7%; revenue per dollar of selling 52,961 / 8,274 = 6.4 and 67,357 / 8,331 = 8.1. Operating margin 15,353 / 52,961 = 29.0%; 17,678 / 57,399 = 30.8%; 20,606 / 67,357 = 30.6%; before amortisation (15,353 + 3,010) / 52,961 = 34.7%, (17,678 + 2,307) / 57,399 = 34.8%, (20,606 + 1,671) / 67,357 = 33.1%; amortisation 1,671 / 67,357 = 2.5%; non-GAAP less GAAP operating income 28.9 - 20.6 = 8.3 bn. Headcount 162,000 - 141,000 = 21,000, 21,000 / 162,000 = 13%. Headcount against the fiscal 2023 peak 164,000 - 141,000 = 23,000. Hardware FY2015 to FY2026 3,084 / 5,205 - 1 = -40.7%. Amortisation Q1 420 - 202 = 218. Stock compensation plus restructuring FY2026 4,811 + 1,838 = 6,649. Americas 44,478 / 36,339 - 1 = 22.4%; Americas share 23,679 / 42,440 = 55.8% (FY2022), 33,122 / 52,961 = 62.5% (FY2024), 44,478 / 67,357 = 66.0% (FY2026), 13,711 / 19,345 = 70.9% (Q1 FY2027); Asia Pacific 7,582 / 6,750 - 1 = 12.3%; EMEA plus Asia Pacific Q1 FY2027 3,726 + 1,908 = 5,634. US long-lived assets 102,717 / 45,439 = 2.3 times. Free cash flow FY2025 20,821 - 21,215 = -394; FY2024 18,673 - 6,866 = 11,807. Capital expenditure share of revenue 6,866 / 52,961 = 13%; 21,215 / 57,399 = 37%; 55,663 / 67,357 = 83%; 28,499 / 19,345 = 147%. Property added 127,845 - 99,957 = 27,888. Q1 FY2027 operating cash flow excluding prepayments 23,103 - 11,363 = 11,740; prepayments share 11,363 / 23,103 = 49%; free cash flow excluding prepayments -5,396 - 11,363 = -16,759. Borrowings 130,105 / 87,202 - 1 = 49%; net debt May 2025 92,568 - 10,786 - 417 = 81,365; May 2026 129,541 - 31,289 - 605 = 97,647; August 2026 7,625 + 117,712 - 36,369 - 708 = 88,260. Interest 1,428 / 923 - 1 = 55%; interest over operating income 1,428 / 6,728 = 21%. Leases not yet commenced over borrowings 288 / 125.3 = 2.3 times; over total assets 288 / 303.3 = 95%. Depreciation 3,156 / 1,351 = 2.3 times. Diluted shares 3,000 / 2,823 - 1 = 6.3%, 3,000 - 2,823 = 177 million; Ellison 1,158.2 / 3,023.7 = 38.3%; pledged 346 / 1,158 = 30%. Remaining performance obligations: 664 / 138 = 4.8 times; 664 / 455 - 1 = 46%; next twelve months 12% x 638 = 77 bn and 13% x 664 = 86 bn; beyond 36 months 100% - 13% - 37% = 50%; quarterly increases 455 - 138 = 317, 523 - 455 = 68, 553 - 523 = 30, 638 - 553 = 85, 664 - 638 = 26. Targets: 225 / 67.357 = 3.3 times; 225 - 24.5 = about 200 bn; 144 / 18 = 8 times; 20 / 2.4 = 8.3 times; Q1 FY2027 revenue 19,345 / 90,000 = 21.5% of guidance. Other: total assets 303,259 - 261,759 = 41,500 in one quarter; revenue FY2026 against FY2023 67,357 / 49,954 - 1 = 34.8%; cloud infrastructure Q1 FY2027 over Q4 FY2026 7,388 - 5,787 = 1,601; quarterly steps 4,079 - 3,347 = 732, 4,888 - 4,079 = 809, 5,787 - 4,888 = 899; cloud applications share 3,839 / 14,926 = 25.7% (Q1 FY2026) and 4,219 / 19,345 = 21.8% (Q1 FY2027); dividends over support 5,787 / 19,804 = 29.2%; interest, research and dividends 4,599 + 10,272 + 5,787 = 20,658; support FY2015 to FY2026 19,804 - 18,847 = 957; US revenue share 39,835 / 67,357 = 59.1%. Trailing twelve months to August 2026: revenue 67,357 - 14,926 + 19,345 = 71,776; net income 17,087 - 2,927 + 4,760 = 18,920; diluted EPS 5.83 - 1.01 + 1.56 = 6.38; P/E 421,930 / 18,920 = 22.3; P/S 421,930 / 71,776 = 5.88 - revenue mix, regional shares and concentration. — FY2015-Q1 FY2027 · publ. September 2026 · source ↗
    Method: Arithmetic on figures reported in Oracle's Forms 10-K and 10-Q, results releases and market data; operands shown in the source line.
  5. ReportedCerner contributed $5.9 billion to Oracle's revenue in fiscal 2023, about 11.8% of the year's total, and it is why the services line jumped from $3,205 million in fiscal 2022 to $5,594 million in fiscal 2023.
    Oracle Form 10-K for fiscal 2023 - the Cerner acquisition, its purchase price allocation and revenue contribution. — FY2023 · publ. June 2023 · source ↗
  6. ReportedIts annual impairment tests did not result in a goodwill impairment charge, and it recognised no impairment in fiscal 2025 or 2024.
    Oracle Corporation Form 10-K for fiscal 2026 (year ended 31 May 2026) - financial statements and notes: income statement, cash flow, borrowings, leases, equity and commitments. — FY2026 · publ. 22 June 2026 · source ↗
  7. ReportedIt now sells Cerner's products as Oracle Health and says a new AI patient care system will push the business's growth "to double-digits in fiscal year 2027".
    Oracle fourth-quarter and fiscal 2026 results release, Form 8-K exhibit 99.1 - financing, $75 billion of prepaid and customer-supplied hardware, Oracle Health and multicloud. — FY2026 · publ. 10 June 2026 · source ↗
  8. ReportedHealth records are subject to privacy rules and government contracting, and Oracle's annual report already carries a privacy class action in the Netherlands.
    Oracle Corporation Form 10-K for fiscal 2026 (year ended 31 May 2026) - Item 1A risk factors: customer concentration and credit, multicloud, lease terms, credit ratings, export rules. — FY2026 · publ. 22 June 2026 · source ↗
Sources
Generated September 25, 2026